Evaxion (ADR) (EVAX)
Decodes immune biology with AI to build vaccine candidates and partner programs.
$3.00
Pre-market−0.09 (−3.05%)
At close$3.10(+3.86%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions15 holders · as of Mar 31, 2026 | 5.20% | 328.6K ADS | |
| Insiders10 holders · as of Apr 24, 2026 | 4.58% | 289.2K ADS | |
| Otherremainder | 90.22% | 5.70M ADS |
6.32M ADS (1 ADS = 50 ordinary shares) as of Sep 1, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (8.34M in the company's Sep 3, 2026 report, 6.32M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
15 holders · 328.6K shares · 5 new positions · 7 increased · 3 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 74.7K | 1.18% | 0 | May 15, 2026 |
| Rathbones Group PLC | 45.7K | 0.72% | +45.7Knew | Jun 9, 2026 |
| Renaissance Technologies LLC | 39.2K | 0.62% | +39.2Knew | May 14, 2026 |
| Annis Gardner Whiting Capital Advisors, LLC | 30.0K | 0.47% | +30.0Knew | May 6, 2026 |
| XTX Topco Ltd | 22.1K | 0.35% | +22.1Knew | May 15, 2026 |
| Rhumbline Advisers | 21.7K | 0.34% | +569 | May 12, 2026 |
| Stonepine Capital Management, LLC | 19.7K | 0.31% | −287 | May 14, 2026 |
| Boothbay Fund Management, LLC | 18.4K | 0.29% | 0 | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Merck & Co., Inc. | 19.96% | 13G | Feb 3, 2025 ↗ | |
| Steven Boydincl. Armistice Capital, LLC | 9.99% | Nov 14, 2024 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.